Intranasal delivery of DNA encoding antigens of Mycobacterium tuberculosis by non-pathogenic invasive Escherichia coli

Paola Brun, Antonella Zumbo, Ignazio Castagliuolo, Giovanni Delogu, Filippo Manfrin, Michela Sali, Giovanni Fadda, Catherine Grillot-Courvalin, Giorgio Palù, Riccardo Manganelli

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Naturally invasive bacteria have been successfully used for mucosal delivery of DNA vaccines against bacterial, viral and tumour antigens. Recently, an alternative delivery system based on a genetically modified mutant of the non-pathogenic commensal bacterium Escherichia coli, was developed and successfully used to deliver therapeutic genes and immunogenic proteins to epithelial cells in vivo. In this work, we used these recombinant invasive bacteria to deliver DNA vaccines against two Mycobacterium tuberculosis proteins (FbpA, and HtpX) following intranasal administration. Both DNA vaccines were able to induce an antigen-specific T-cell response. Moreover, mice immunized with the recombinant bacteria carrying the DNA vaccine encoding HtpX, were significatively protected from challenge with M. tuberculosis.

Original languageEnglish
Pages (from-to)1934-1941
Number of pages8
JournalVaccine
Volume26
Issue number16
DOIs
Publication statusPublished - Apr 7 2008

Fingerprint

DNA Vaccines
Mycobacterium tuberculosis
recombinant vaccines
Escherichia coli
antigens
Bacteria
DNA
bacteria
Bacterial Antigens
intranasal administration
Intranasal Administration
Viral Tumor Antigens
epithelial cells
proteins
T-lymphocytes
Epithelial Cells
T-Lymphocytes
Antigens
mutants
therapeutics

Keywords

  • Delivery system
  • DNA vaccine
  • Live recombinant vaccine
  • Mycobacterium tuberculosis
  • Tuberculosis

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

Brun, P., Zumbo, A., Castagliuolo, I., Delogu, G., Manfrin, F., Sali, M., ... Manganelli, R. (2008). Intranasal delivery of DNA encoding antigens of Mycobacterium tuberculosis by non-pathogenic invasive Escherichia coli. Vaccine, 26(16), 1934-1941. https://doi.org/10.1016/j.vaccine.2008.02.023

Intranasal delivery of DNA encoding antigens of Mycobacterium tuberculosis by non-pathogenic invasive Escherichia coli. / Brun, Paola; Zumbo, Antonella; Castagliuolo, Ignazio; Delogu, Giovanni; Manfrin, Filippo; Sali, Michela; Fadda, Giovanni; Grillot-Courvalin, Catherine; Palù, Giorgio; Manganelli, Riccardo.

In: Vaccine, Vol. 26, No. 16, 07.04.2008, p. 1934-1941.

Research output: Contribution to journalArticle

Brun, P, Zumbo, A, Castagliuolo, I, Delogu, G, Manfrin, F, Sali, M, Fadda, G, Grillot-Courvalin, C, Palù, G & Manganelli, R 2008, 'Intranasal delivery of DNA encoding antigens of Mycobacterium tuberculosis by non-pathogenic invasive Escherichia coli', Vaccine, vol. 26, no. 16, pp. 1934-1941. https://doi.org/10.1016/j.vaccine.2008.02.023
Brun, Paola ; Zumbo, Antonella ; Castagliuolo, Ignazio ; Delogu, Giovanni ; Manfrin, Filippo ; Sali, Michela ; Fadda, Giovanni ; Grillot-Courvalin, Catherine ; Palù, Giorgio ; Manganelli, Riccardo. / Intranasal delivery of DNA encoding antigens of Mycobacterium tuberculosis by non-pathogenic invasive Escherichia coli. In: Vaccine. 2008 ; Vol. 26, No. 16. pp. 1934-1941.
@article{0c6039e26f11430fba1bd238c9772542,
title = "Intranasal delivery of DNA encoding antigens of Mycobacterium tuberculosis by non-pathogenic invasive Escherichia coli",
abstract = "Naturally invasive bacteria have been successfully used for mucosal delivery of DNA vaccines against bacterial, viral and tumour antigens. Recently, an alternative delivery system based on a genetically modified mutant of the non-pathogenic commensal bacterium Escherichia coli, was developed and successfully used to deliver therapeutic genes and immunogenic proteins to epithelial cells in vivo. In this work, we used these recombinant invasive bacteria to deliver DNA vaccines against two Mycobacterium tuberculosis proteins (FbpA, and HtpX) following intranasal administration. Both DNA vaccines were able to induce an antigen-specific T-cell response. Moreover, mice immunized with the recombinant bacteria carrying the DNA vaccine encoding HtpX, were significatively protected from challenge with M. tuberculosis.",
keywords = "Delivery system, DNA vaccine, Live recombinant vaccine, Mycobacterium tuberculosis, Tuberculosis",
author = "Paola Brun and Antonella Zumbo and Ignazio Castagliuolo and Giovanni Delogu and Filippo Manfrin and Michela Sali and Giovanni Fadda and Catherine Grillot-Courvalin and Giorgio Pal{\`u} and Riccardo Manganelli",
year = "2008",
month = "4",
day = "7",
doi = "10.1016/j.vaccine.2008.02.023",
language = "English",
volume = "26",
pages = "1934--1941",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "16",

}

TY - JOUR

T1 - Intranasal delivery of DNA encoding antigens of Mycobacterium tuberculosis by non-pathogenic invasive Escherichia coli

AU - Brun, Paola

AU - Zumbo, Antonella

AU - Castagliuolo, Ignazio

AU - Delogu, Giovanni

AU - Manfrin, Filippo

AU - Sali, Michela

AU - Fadda, Giovanni

AU - Grillot-Courvalin, Catherine

AU - Palù, Giorgio

AU - Manganelli, Riccardo

PY - 2008/4/7

Y1 - 2008/4/7

N2 - Naturally invasive bacteria have been successfully used for mucosal delivery of DNA vaccines against bacterial, viral and tumour antigens. Recently, an alternative delivery system based on a genetically modified mutant of the non-pathogenic commensal bacterium Escherichia coli, was developed and successfully used to deliver therapeutic genes and immunogenic proteins to epithelial cells in vivo. In this work, we used these recombinant invasive bacteria to deliver DNA vaccines against two Mycobacterium tuberculosis proteins (FbpA, and HtpX) following intranasal administration. Both DNA vaccines were able to induce an antigen-specific T-cell response. Moreover, mice immunized with the recombinant bacteria carrying the DNA vaccine encoding HtpX, were significatively protected from challenge with M. tuberculosis.

AB - Naturally invasive bacteria have been successfully used for mucosal delivery of DNA vaccines against bacterial, viral and tumour antigens. Recently, an alternative delivery system based on a genetically modified mutant of the non-pathogenic commensal bacterium Escherichia coli, was developed and successfully used to deliver therapeutic genes and immunogenic proteins to epithelial cells in vivo. In this work, we used these recombinant invasive bacteria to deliver DNA vaccines against two Mycobacterium tuberculosis proteins (FbpA, and HtpX) following intranasal administration. Both DNA vaccines were able to induce an antigen-specific T-cell response. Moreover, mice immunized with the recombinant bacteria carrying the DNA vaccine encoding HtpX, were significatively protected from challenge with M. tuberculosis.

KW - Delivery system

KW - DNA vaccine

KW - Live recombinant vaccine

KW - Mycobacterium tuberculosis

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=40849101451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40849101451&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2008.02.023

DO - 10.1016/j.vaccine.2008.02.023

M3 - Article

C2 - 18342411

AN - SCOPUS:40849101451

VL - 26

SP - 1934

EP - 1941

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 16

ER -